相关实验视频

Updated: Jun 29, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

前列腺癌的治疗与Lu-PSMA的177

Hojjat Ahmadzadehfar¹, Robert Seifert², Ali Afshar-Oromieh²

¹Department of Nuclear Medicine, Klinikum Westfalen, Dortmund, Germany; Department of Nuclear Medicine, Institute of Radiology, Neuroradiology and Nuclear Medicine, University Hospital Knappschaftskrankenhaus, Bochum, Germany.

Seminars in nuclear medicine

|April 3, 2024

概括

卢-177 PSMA (Lu-PSMA) 疗法为转移性割抵抗性前列腺癌 (mCRPC) 提供了显著的进展. 本综述探讨了其使用,有效性和安全性,倡导个性化治疗方法.

科学领域:

在瘤学瘤学.
核医学就是核医学.
放射性药物疗法是一种放射性药物疗法.

背景情况:

前列腺癌的管理已经发展到有针对性的疗法.
转移性割抵抗性前列腺癌 (mCRPC) 存在重大治疗挑战.
前列腺特异性膜抗原 (PSMA) 向治疗已经成为一个有前途的方法.

研究的目的:

审查目前针对PSMA的诊断和治疗,特别是177Lu-PSMA-617在前列腺癌中的作用.
分析放射性干疗法 (RLT) 的指示,患者选择和治疗执行情况.
评估与其他mCRPC治疗相比,Lu-PSMA的比较有效性和安全性.

主要方法:

审查现有的文献和临床试验数据,包括VISION试验.
进行对比疗效研究的批判性审查 (Lu-PSMA与cabazitaxel,Ra-223对比).
讨论正在进行的化学疗法和激素敏感前列腺癌环境中的研究.

主要成果:

177Lu-PSMA-617已被批准用于化疗后和ARPI mCRPC患者.
证据支持Lu-PSMA的疗效,目前正在进行的研究正在探索更广泛的应用.
毒性是一个关键的安全问题,需要进一步调查.

结论:

针对PSMA的向治疗代表了前列腺癌治疗的重大进步.
建议将其整合到多模式,以患者为中心的策略中.
进一步的比较研究和现实世界的数据对于优化治疗方案和结果至关重要.

更多相关视频

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET